April 8, 2021Open Access

Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials

Key Points

Key points are not available for this paper at this time.

Abstract

There is strong evidence supporting clinically relevant anti-inflammatory and antioxidant effects of GLP-1RAs. This may be used to guide future targeted clinical use of GLP-1RAs and the development of medications seeking to target the cardioprotective properties of GLP-1RAs.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Bray et al. (Thu,) studied this question.

synapsesocial.com/papers/69d969ec8988aeabbe6853c4 https://doi.org/https://doi.org/10.1111/dom.14399

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Performing meta-analysis with incomplete statistical information in clinical trials2008 · 156 citations
2A Randomized Study to Compare the Effects of Once-Weekly Dulaglutide Injection and Once-Daily Glimepiride on Glucose Fluctuation of Type 2 Diabetes Mellitus Patients: A 26-Week Follow-Up2019 · 21 citations
3Elevated Levels of Oxidative Stress as a Prognostic Predictor of Major Adverse Cardiovascular Events in Patients with Coronary Artery Disease2012 · 56 citations
4One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress2010 · 135 citations
5Plasma 8‐epi‐PGF<sub>2α</sub> levels are elevated in individuals with non‐insulin dependent diabetes mellitus1995 · 392 citations

Bookmark

View Full Paper